ArticleOncotarget2014
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways.
Anne Y Saiki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papertrialcites it